Kelly Johnson‐Wood
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Prion Diseases and Protein Misfolding, Amyloidosis: Diagnosis, Treatment, Outcomes, Cholinesterase and Neurodegenerative Diseases, Computational Drug Discovery Methods
Most-Cited Works
- → Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse(1999)3,141 cited
- → Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein(1995)2,495 cited
- → Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease(2000)1,999 cited
- → High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation(2000)1,860 cited
- → Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice(1997)1,262 cited
- → Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain(2001)877 cited
- → Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease(1995)693 cited
- → Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer disease(1997)656 cited
- → The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II(1989)461 cited
- → Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease(1997)418 cited